Phathom Pharmaceuticals (PHAT) Other Working Capital Changes (2018 - 2026)

Phathom Pharmaceuticals (PHAT) has 9 years of Other Working Capital Changes data on file, last reported at -$6.9 million in Q1 2026.

• Other Working Capital Changes for Q1 2026 came in at -$6.9 million, up 11.42% year-over-year; the trailing twelve-month figure through Mar 2026 was -$4.6 million (down 1595.47% YoY), and the FY2025 annual result was -$5.5 million, down 171.86% from the prior year.
• Other Working Capital Changes declined to -$6.9 million in Q1 2026 per PHAT's latest filing, from $2.1 million in the prior quarter.
• Over five years, Other Working Capital Changes peaked at $5.9 million in Q4 2024 and troughed at -$7.8 million in Q1 2025.
• A 5-year average of $304000.0 and a median of $254000.0 in 2023 frame the typical range for Other Working Capital Changes.
• The sharpest annual moves came in 2024 and 2025: Other Working Capital Changes jumped 2218.11% in 2024, then plunged 1647.2% in 2025.
• A 5-year view of Other Working Capital Changes shows it stood at $4.2 million in 2022, then tumbled by 93.88% to $254000.0 in 2023, then jumped by 2218.11% to $5.9 million in 2024, then tumbled by 63.91% to $2.1 million in 2025, then tumbled by 425.55% to -$6.9 million in 2026.
• Business Quant data shows PHAT's Other Working Capital Changes at -$6.9 million in Q1 2026, $2.1 million in Q4 2025, and -$1.4 million in Q3 2025.